Transcend Therapeutics
Clinical trials sponsored by Transcend Therapeutics, explained in plain language.
-
Experimental PTSD treatment shows promise in clinical trial
Disease control CompletedThis study tested whether methylone, given as weekly treatments, can safely reduce PTSD symptoms in adults. Researchers enrolled 62 people with severe PTSD who had tried at least one previous treatment. They measured changes in PTSD symptoms, depression, and daily functioning ove…
Phase: PHASE2 • Sponsor: Transcend Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Experimental drug tested as new hope for tough PTSD cases
Disease control CompletedThis study tested whether methylone, a medication similar to MDMA, could safely help adults with moderate to severe PTSD. It involved 79 participants who had not improved with standard treatments. Participants received weekly methylone doses for a month, followed by several weeks…
Phase: PHASE1, PHASE2 • Sponsor: Transcend Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Year-Long trial tests psychedelic Drug's staying power against PTSD
Disease control CompletedThis study followed 44 people with PTSD for a full year to see if treatment with the drug methylone (TSND-201) provides lasting relief. Participants were monitored monthly for their PTSD symptoms and safety. If their symptoms returned during the year, they could be eligible to re…
Phase: PHASE2 • Sponsor: Transcend Therapeutics • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Scientists test psychedelic Drug's safety in first human study
Knowledge-focused CompletedThis early study tested the safety and how the body processes methylone, a substance being researched for PTSD, in healthy volunteers. Forty healthy adults received increasing doses while researchers measured drug levels in their blood and monitored for side effects. The goal was…
Phase: PHASE1 • Sponsor: Transcend Therapeutics • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC